Phase 1
60 Years
N/A
60 Years
N/A
Open (Enrolling)
Both
Acute Myeloid Leukemia
Both
Acute Myeloid Leukemia
Trial Information
Inclusion Criteria:
- Patients who completed the Study 311-10-001 and were judged that there was no relapse
by any inspections in the end of the study.
- Patients who are capable of giving informed consent
Exclusion Criteria:
- Patients failed to discontinue the Study 311-10-001 even though patients met the
discontinuation criteria.
- Patients who have participated in any other clinical trials , excluding the Study
311-10-001).
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Occurrence of severe toxicities as defined in the protocol
Safety Issue:
Yes
Authority:
Japan: Ministry of Health, Labor and Welfare
Study ID:
311-10-002
NCT ID:
NCT01475370
Start Date:
November 2011
Completion Date:
December 2018
Related Keywords:
- Acute Myeloid Leukemia
- Acute myeloid leukemia
- WT1
- Leukemia
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
Name | Location |
|---|
